Update: 23.07.2024
Last week: 28 week 2024 (08.07.2024 - 14.07.2024)
Last full month: June 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 284 | 22.4% | 13.8% | 1.8 | 15 988 012 | 17.9% | 10.2% | 1.1 | 6.5% |
| MoM | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| YTD | 201 706 | 18.8% | 11.3% | 2.5 | 440 599 509 | 41.4% | 9.4% | 2 | -7.4% |
| MAT | 372 754 | 25.7% | 10.4% | 1.9 | 785 765 694 | 44.9% | 8.7% | 1.5 | 2.7% |
| BRAINMAX | |||||||||
| WoW | 1 341 | 7.6% | 100.0% | 0 | 4 977 089 | 4.8% | 100.0% | 0 | 7.6% |
| MoM | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| YTD | 29 477 | 40.6% | 100.0% | 0 | 107 514 712 | 52.7% | 100.0% | 0 | 40.6% |
| MAT | 55 165 | 77.4% | 100.0% | 0 | 198 094 738 | 92.3% | 100.0% | 0 | 77.4% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 827 | -0.9% | 46.2% | -0.8 | 49 574 879 | -0.6% | 38.1% | -0.6 | 0.8% |
| MoM | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| YTD | 480 718 | -3.3% | 44.8% | 1 | 1 516 858 437 | 0.2% | 36.6% | -2.7 | -5.5% |
| MAT | 852 708 | 6.2% | 45.5% | 1.1 | 2 695 169 322 | 12.9% | 38.1% | -1.4 | 3.5% |
| MIGRENIUM | |||||||||
| WoW | 10 626 | 0.4% | 0.5% | 0 | 3 570 838 | -0.0% | 0.7% | 0 | 5.6% |
| MoM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| YTD | 332 808 | -3.7% | 0.5% | -0.1 | 101 874 492 | 62.9% | 0.7% | 0.2 | 10.9% |
| MAT | 628 965 | -1.2% | 0.5% | -0.1 | 162 014 934 | 40.1% | 0.6% | 0.1 | 14.8% |
| MODELAX-N | |||||||||
| WoW | 24 212 | 3.5% | 20.1% | 0 | 11 320 470 | 3.8% | 13.5% | 0 | 3.6% |
| MoM | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| YTD | 843 300 | 39.9% | 23.5% | 4.8 | 359 614 622 | 90.0% | 15.0% | 4.6 | 11.5% |
| MAT | 1 408 562 | 67.9% | 21.2% | 6.2 | 553 144 939 | 105.5% | 12.9% | 4.4 | 19.2% |
| REDUXIN | |||||||||
| WoW | 11 263 | 3.0% | 32.8% | 0.7 | 57 984 662 | 1.9% | 44.6% | 0.4 | 0.8% |
| MoM | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| YTD | 353 022 | -8.5% | 32.9% | -1.1 | 1 900 751 748 | 16.2% | 45.9% | 3.4 | -5.5% |
| MAT | 604 895 | -2.4% | 32.3% | -2 | 3 138 424 339 | 21.1% | 44.3% | 1.5 | 3.5% |
| REDUXIN FORTE | |||||||||
| WoW | 3 231 | 1.8% | 9.4% | 0.1 | 13 782 913 | 2.3% | 10.6% | 0.1 | 0.8% |
| MoM | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| YTD | 93 925 | 1.4% | 8.8% | 0.6 | 408 043 539 | 16.4% | 9.8% | 0.7 | -5.5% |
| MAT | 167 311 | 15.8% | 8.9% | 0.9 | 711 011 449 | 29.0% | 10.0% | 0.9 | 3.5% |
| SALVISAR | |||||||||
| WoW | 7 714 | -2.4% | 1.1% | -0.1 | 3 498 364 | -0.7% | 1.1% | -0.1 | 3.8% |
| MoM | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
| YTD | 287 222 | 1.9% | 1.4% | 0 | 115 821 647 | 26.9% | 1.2% | 0.1 | -0.2% |
| MAT | 503 842 | -12.3% | 1.3% | -0.2 | 188 297 908 | -2.6% | 1.1% | -0.2 | 4.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 201 706 | 18.8% | 11.3% | 2.5 | 440 599 509 | 41.4% | 9.4% | 2 | -7.4% |
| BRAINMAX | 29 477 | 40.6% | 100.0% | 0 | 107 514 712 | 52.7% | 100.0% | 0 | 40.6% |
| GOLDLINE PLUS | 480 718 | -3.3% | 44.8% | 1 | 1 516 858 437 | 0.2% | 36.6% | -2.7 | -5.5% |
| MIGRENIUM | 332 808 | -3.7% | 0.5% | -0.1 | 101 874 492 | 62.9% | 0.7% | 0.2 | 10.9% |
| MODELAX-N | 843 300 | 39.9% | 23.5% | 4.8 | 359 614 622 | 90.0% | 15.0% | 4.6 | 11.5% |
| REDUXIN CAPS | 353 022 | -8.5% | 32.9% | -1.1 | 1 900 751 748 | 16.2% | 45.9% | 3.4 | -5.5% |
| REDUXIN FORTE | 93 925 | 1.4% | 8.8% | 0.6 | 408 043 539 | 16.4% | 9.8% | 0.7 | -5.5% |
| SALVISAR | 287 222 | 1.9% | 1.4% | 0 | 115 821 647 | 26.9% | 1.2% | 0.1 | -0.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 372 754 | 25.7% | 10.4% | 1.9 | 785 765 694 | 44.9% | 8.7% | 1.5 | 2.7% |
| BRAINMAX | 55 165 | 77.4% | 100.0% | 0 | 198 094 738 | 92.3% | 100.0% | 0 | 77.4% |
| GOLDLINE PLUS | 852 708 | 6.2% | 45.5% | 1.1 | 2 695 169 322 | 12.9% | 38.1% | -1.4 | 3.5% |
| MIGRENIUM | 628 965 | -1.2% | 0.5% | -0.1 | 162 014 934 | 40.1% | 0.6% | 0.1 | 14.8% |
| MODELAX-N | 1 408 562 | 67.9% | 21.2% | 6.2 | 553 144 939 | 105.5% | 12.9% | 4.4 | 19.2% |
| REDUXIN CAPS | 604 895 | -2.4% | 32.3% | -2 | 3 138 424 339 | 21.1% | 44.3% | 1.5 | 3.5% |
| REDUXIN FORTE | 167 311 | 15.8% | 8.9% | 0.9 | 711 011 449 | 29.0% | 10.0% | 0.9 | 3.5% |
| SALVISAR | 503 842 | -12.3% | 1.3% | -0.2 | 188 297 908 | -2.6% | 1.1% | -0.2 | 4.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 284 | 22.4% | 13.8% | 1.8 | 15 988 012 | 17.9% | 10.2% | 1.1 | 6.5% |
| BRAINMAX | 1 341 | 7.6% | 100.0% | 0 | 4 977 089 | 4.8% | 100.0% | 0 | 7.6% |
| GOLDLINE PLUS | 15 827 | -0.9% | 46.2% | -0.8 | 49 574 879 | -0.6% | 38.1% | -0.6 | 0.8% |
| MIGRENIUM | 10 626 | 0.4% | 0.5% | 0 | 3 570 838 | -0.0% | 0.7% | 0 | 5.6% |
| MODELAX-N | 24 212 | 3.5% | 20.1% | 0 | 11 320 470 | 3.8% | 13.5% | 0 | 3.6% |
| REDUXIN CAPS | 11 263 | 3.0% | 32.8% | 0.7 | 57 984 662 | 1.9% | 44.6% | 0.4 | 0.8% |
| REDUXIN FORTE | 3 231 | 1.8% | 9.4% | 0.1 | 13 782 913 | 2.3% | 10.6% | 0.1 | 0.8% |
| SALVISAR | 7 714 | -2.4% | 1.1% | -0.1 | 3 498 364 | -0.7% | 1.1% | -0.1 | 3.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| BRAINMAX | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| GOLDLINE PLUS | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| MIGRENIUM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| MODELAX-N | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| REDUXIN CAPS | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| REDUXIN FORTE | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| SALVISAR | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs